Related Experiment Video

Updated: May 29, 2026

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation
06:13

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation

Published on: June 20, 2018

Inferior turbinate hypertrophy radiofrequency management for children with cystic fibrosis

H Abou Mayaleh1, L Benichou, O Senouci-Bereksi

  • 1ENT Head and Neck Surgery Departement, Robert Bisson's Hospital, 4 rue Roger Aini, BP 14107 Lisieux, France.

Revue De Laryngologie - Otologie - Rhinologie
|August 27, 2011
PubMed

Insights

Radiofrequency treatment for inferior turbinate hypertrophy in children with cystic fibrosis offers initial symptom relief. While effectiveness wanes over time, results remain satisfactory for up to two years, suggesting potential for repeat treatments.

Area of Science:

  • Otorhinolaryngology
  • Pediatric Surgery
  • Medical Technology

Background:

  • Inferior turbinate hypertrophy is a common issue in children with cystic fibrosis.
  • Effective management strategies are crucial for improving quality of life.

Purpose of the Study:

  • To assess the efficacy and relevance of radiofrequency techniques for treating inferior turbinate hypertrophy in pediatric cystic fibrosis patients.
  • Evaluate the long-term outcomes of radiofrequency treatment.

Main Methods:

  • A cohort of 41 pediatric cystic fibrosis patients with inferior turbinate hypertrophy was studied over two years.
  • Clinical and radiological examinations were used to analyze the postoperative phase and treatment effectiveness.

Main Results:

  • 100% of patients experienced clinical symptom improvement by three months post-surgery.
  • Radiofrequency effectiveness on turbinate tissue decreased after one year, worsening over time.
  • Postoperative results remained satisfactory at both one and two-year follow-ups.

Conclusions:

  • Radiofrequency is a recommended treatment for inferior turbinate hypertrophy in pediatric cystic fibrosis patients due to its low-risk profile and preservative nature.
  • While benefits diminish over time, satisfactory outcomes persist beyond two years.
  • Consideration for repeat radiofrequency sessions after two years is often beneficial.
Abstract

More Related Videos

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...